Roisin McCallion is Business Development and Investment Director at the University of Manchester Innovation Factory.  She holds a PhD in drug delivery, conducting postdoctoral research in cellular and molecular mechanisms of tumorigenesis and wound healing before joining Smith & Nephew plc as a research scientist, then moving into Business Development.  Roisin has 20 years of Corporate M&A and Licensing experience, prior to joining the Innovation Factory in 2017 to lead commercialisation of University of Manchester inventions.

roisin.mccallion@uominnovationfactory.com
+44 (0)161 603 7772 (office)*
+44 (0)7552 008 131 (mobile)

*As a result of lockdown related to Covid-19, office landline numbers are not currently being monitored. Therefore, please email or phone an alternative number, where possible.

Roisin's involvement

Life SciencesMedtech

Rheumatoid relief

While therapies to help with Rheumatoid arthritis have become more successful in recent years, there still remains a significant amount of patients for whom the treatment has no effect. A new, more effective method for targeting patients that will respond to treatment could result in better outcomes and cost savings.

Life SciencesPharma

Spotting cell senescence - SenTraGor

SenTraGor is an innovative, easy-to-use reagent for the reliable detection of Senescence in cells.
abstract image of tendon

Health and Biotech

Fixing Achilles

An innovative device designed to be delivered by keyhole surgery which specifically addresses the biology of a regenerating tendon to improve outcomes for patients.

Life SciencesPharma

The missing link - Link Biologics

Link Biologics is developing Link_TSG6, a protein biological, to treat common inflammatory and degenerative disorders of the ocular and musculoskeletal systems.